Workflow
Stryker(SYK)
icon
Search documents
Stryker completes acquisition of SERF SAS
Prnewswire· 2024-03-21 11:15
MAHWAH, N.J., USA, March 21, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France-based joint replacement company, from Menix. "The acquisition of SERF SAS further strengthens our global portfolio and reinforces our dedication to orthopaedic excellence," said Katherine Truppi, President of Stryker's Joint Replacement division. "We welcome the SERF SAS team to Stryker and look fo ...
Stryker (SYK) Completes First Arthroplasty Surgery in Europe
Zacks Investment Research· 2024-03-06 14:51
Stryker Corporation (SYK) recently announced that the first shoulder arthroplasty surgery using Blueprint Mixed Reality (MR) Guidance has been completed in Europe.First shoulder arthroplasty surgery has been completed in Europe by Professor Julien Berhouet, MD, PhD, CHRU Tours Hospital, France, and Dr. Lionel Neyton, MD, orthopedic shoulder surgeon at Centre Orthopédique Santy and Hôpital Privé Jean Mermoz in Lyon, France.Price PerformanceFor the past six months, SYK’s shares have rallied 22.0% compared wit ...
Stryker(SYK) - 2023 Q4 - Annual Report
2024-02-13 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-13149 STRYKER CORPORATION (Exact name of registrant as specified in its charter) | Michigan | 38-1239739 | | --- | --- | | (State of incorporation) | (I.R.S. Employer Identifica ...
Stryker: Rerating Higher
Seeking Alpha· 2024-02-07 13:19
gorodenkoff/iStock via Getty Images Stryker (NYSE:SYK) is a leading medical technology company with a diversified product portfolio. Target markets include orthopedics, spine, surgical instruments, neurotechnology, and medical and surgical equipment. Stryker has a strong position within robotics for orthopedic surgery and is also demonstrating solid growth across its other businesses. While the company's valuation has risen substantially in recent years, this is in response to accelerating growth, impro ...
Stryker declares a $0.80 per share quarterly dividend
Newsfilter· 2024-02-07 13:00
Portage, Michigan, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable April 30, 2024 to shareholders of record at the close of business on March 29, 2024, representing an increase of 6.7% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers inno ...
Stryker: A Dividend Growth Powerhouse I'd Like To Own
Seeking Alpha· 2024-02-02 13:00
A surgical team works in the operating room. gorodenkoff As an investor, I'm evolving quite a bit after six years of investing with real money. When I first began, I had this slant toward value over growth that was ingrained in me. This pull to value and high yield admittedly cost me capital appreciation on many occasions. In recent years, I have come around a bit more to the mindset that for quality, overpaying in the near term is inevitable. After all, wonderful businesses can make a modest overvaluatio ...
Stryker's (SYK) Q4 Earnings & Revenues Surpass Estimates
Zacks Investment Research· 2024-01-31 16:50
Stryker Corporation (SYK) reported fourth-quarter 2023 adjusted earnings per share (EPS) of $3.46, which beat the Zacks Consensus Estimate of $3.27 by 5.81%. The bottom line also improved 15.3% year over year.GAAP EPS was $2.98, up 102.7% from the year-ago quarter.Price PerformanceSYK’s shares have gained 13.4% in the past six months compared with the industry's gain of 0.8%. The S&P 500 Index increased 7.6% in the same period.Image Source: Zacks Investment ResearchRevenue DetailsRevenues totaled $5.8 billi ...
Stryker Expands Prophecy® Surgical Planning System to Include the New Footprint™, Offering Surgeons a Comprehensive View of the Foot and Ankle
Businesswire· 2024-01-31 13:10
PORTAGE, Mich.--(BUSINESS WIRE)--Stryker (NYSE: SYK), a global leader in medical technologies, today announced the launch of Prophecy Footprint, an expansion of the Prophecy Surgical Planning system, offering comprehensive surgical planning across the entire foot. The system will be demonstrated at the American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting, Tampa Bay, Fla., Feb. 1-4 (booth #919). The launch of Prophecy Footprint also coincides with the tenth anniversary of Stryker’s Infinity ...
Stryker(SYK) - 2023 Q4 - Earnings Call Transcript
2024-01-31 02:28
Stryker Corporation (NYSE:SYK) Q4 2023 Earnings Conference Call January 30, 2024 4:30 PM ET Company Participants Kevin Lobo – Chair and Chief Executive Officer Jason Beach – Vice President-Investor Relations Glenn Boehnlein – Chief Financial Officer Conference Call Participants Robbie Marcus – JPMorgan Lawrence Biegelsen – Wells Fargo Ryan Zimmerman – BTIG Joanne Wuensch – Citi Vijay Kumar – Evercore ISI Shagun Singh – RBC Pito Chickering – Deutsche Bank Travis Steed – Bank of America Matthew O’Brien – Pipe ...
Stryker (SYK) Reports Q4 Earnings: What Key Metrics Have to Say
Zacks Investment Research· 2024-01-31 00:36
For the quarter ended December 2023, Stryker (SYK) reported revenue of $5.82 billion, up 11.8% over the same period last year. EPS came in at $3.46, compared to $3.00 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $5.6 billion, representing a surprise of +3.81%. The company delivered an EPS surprise of +5.81%, with the consensus EPS estimate being $3.27.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they c ...